ORPHA:91411
Congenital ptosis
Query health: suspect — Only one of 3 strategies returned hits (phrase).
Publications
1,458
Trials
3
Interventional, condition-specific
Researchers
902
Distinct authors in sample
Gene link
ZFHX4
No Known Disease Relationship
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
ptosis is characterized by superior eyelid drop present at birth.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0008340
- MeSH:C566737
- UMLS:C1867438
- NCIT:C27049
Additional Mondo synonyms (2)
congenital eyelid ptosis · congenital ptosis (disease)
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPartial
No Known Disease Relationship — ZFHX4
- LiteraturePresent
1,458 matched papers (660 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
3 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
1,458
1,458 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
1,458 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
660 in the last 10 years · low confidence
Phrase hits: 1,458 · MeSH hits: 0
Who's working on it?
902
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Diab MM7 papers · 2026
Department of Ophthalmology, Faculty of Medicine, Fayoum University, Al-Fayoum, Egypt.
Papers in Europe PMC - 02Rafizadeh SM7 papers · 2026
Farabi Eye Research Center, Department of Oculofacial Plastic and Reconstructive Surgery, Farabi Eye Hospital, Tehran University of Medical Sciences, South Kargar Street, Qazvin Square, Tehran, 1336616351, Iran. mohsen_raf1354@yahoo.com.
Papers in Europe PMC - 03Cao J5 papers · 2026
From the Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University.
Papers in Europe PMC - 04Li Y5 papers · 2026
Department of Ophthalmology, Pediatric Hospital Affiliated to Fudan University, Anhui Hospital, Anhui Children's Hospital, Hefei, China.
Papers in Europe PMC - 05Liu Z5 papers · 2026
Department of Ophthalmology, Pediatric Hospital Affiliated to Fudan University, Anhui Hospital, Anhui Children's Hospital, Hefei, China.
Papers in Europe PMC - 06Wang X5 papers · 2026
Department of Ophthalmology, Hunan Children's Hospital, No. 86 Ziyuan Road, Changsha City, Hunan Province, China.
Papers in Europe PMC - 07Alahmadawy YA4 papers · 2026
Ophthalmology Department, Faculty of Medicine, Cairo University, Giza, Egypt. dr_y.alahmadawy@cu.edu.eg.
Papers in Europe PMC - 08Allen RC4 papers · 2026
Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
Papers in Europe PMC - 09Cang ZQ4 papers · 2025
From the Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University.
Papers in Europe PMC - 10Fan X4 papers · 2025
From the Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
3
interventional trials for this specific condition
3 interventional trials matched this specific condition name; 1 currently recruiting in our sample. 49 trials are registered for ptosis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
3 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 85.1th percentile).
low confidence · 85.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
3 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07466706·NOT YET RECRUITING·Levator Muscle and Its Aponeurotic Maldevelopment in Congenital Ptosis
Conditions: Congenital Ptosis·Matched via name phrase
Broader category: ptosis
49
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07390578·NOT YET RECRUITING·Upneeq vs. Lumify Ptosis
Conditions: Acquired Ptosis·Matched via name phrase
- NCT07646886·NOT YET RECRUITING·Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis
Conditions: Facial Aging · Melomental Folds · Oral Commissure Ptosis·Matched via name phrase
- NCT07003308·RECRUITING·Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis
Conditions: Ptosis, Eyelid·Matched via name phrase
- NCT07250139·RECRUITING·Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation
Conditions: Dermatochalasis of Upper Eyelid · Ptosis, Eyelid · Blepharoplasty·Matched via name phrase
- NCT04007276·NOT YET RECRUITING·The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
Conditions: Glaucoma · Glaucoma, Open-Angle · Glaucoma; Drugs · Droopy Eyelid·Matched via name phrase
- NCT07197190·NOT YET RECRUITING·Hybrid Autologous Breast Augmentation in Mastopexy With Internal BRA Fixation; Using Local Breast Tissues and Fat Grafting
Conditions: Breast Ptosis·Matched via name phrase
- NCT07419854·RECRUITING·Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
Conditions: Volume Loss (Soft Tissue Ptosis or Atrophy )·Matched via name phrase
Observational and natural-history studies
3 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07534436·RECRUITING·A Prospective Cohort Study on Visual Function and Psychological Conditions Before and After Surgery for Congenital Ptosis
Conditions: Ptosis·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Congenital ptosis" OR "congenital eyelid ptosis" OR "congenital ptosis (disease)"
MeSH descriptor terms unioned into the query: Ptosis, Hereditary Congenital 1
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Congenital ptosis" OR "congenital eyelid ptosis" OR "congenital ptosis (disease)" OR "Ptosis, Hereditary Congenital 1" OR "ZFHX4"
Recall-expansion terms: ZFHX4
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 3 interventional · 3 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"ptosis"
Query health: suspect — strategies attempted: phrase, mesh, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1458) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T04:01:52.013Z
